Pantai Premier Pathology held its first Molecular Pathology Symposium on 22 July 2018. With the theme: Embracing Personalized Medicine.
The symposium was held at Hilton Petaling Jaya Hotel, and well attended by about 150 local and overseas delegates from diverse specialties including oncologists, clinical haematologists, pathologists, physicians, medical officers, medical lab technologists, scientists, research officers and academicians.
It started with an opening address by En Mohd Hareeff Bin Muhammed, Chief Executive Officer of Pantai Premier Pathology. En Hareeff emphasised on the importance of gathering from various fields and to ensure the latest molecular modalities and treatments can be accessible to local patients.
Hence, the aim of this symposium is to discuss the current lead in oncology as well as the practicality of modern molecular technologies to aid clinicians in their patient management by congregate experts from diverse fields of oncology.
The whole event was divided into 5 sessions, in which the first 4 sessions covered the topics of Immunotherapy: Next Step, Molecular Pathology, Haematology Oncology and Case Study Presentation. The last session was the panel discussion on the current updates and challenges in molecular diagnostic era. It was chaired by Prof. Dr. Teo Soo-Hwang, Chief Executive Officer of Cancer Research Malaysia (CRM). While the panellists consist of Chief Executive Officer of Pantai Premier Pathology, Head of Oncology & Radiotherapy Department of HKL, Consultant Clinical Oncologist of Beacon Hospital, Head of Pathologist Malaysia of HKL, Consultant Clinical Haematologist of Pantai Hospital KL and Consultant Oncologist of Gleneagles Kuala Lumpur.
The symposium could not have been held remarkably respective contribution from Pantai Premier Pathology’s partners which include Interscience, ScienceVision, Sysmex, Roche, Qiagen, Biomed Global, Biomedia, MSD, and Gleneagles Kuala Lumpur. They had been sponsoring the occasion and even opened their booths allocated to showcase their products and services from various industries such as molecular diagnostics, genomic solutions, biomedical and life sciences provider, scientific testing and research-based healthcare provider.
THANK YOU TO OUR HONOURED GUESTS AND EXPERTS
Dr. Tho Lye Mun, Consultant Clinical Oncologist, Sunway Medical Centre
Shaun Peterson, Global Commercialization Marketing Manager, Clinical Diagnostics Promega Corporation
Ms. Holly A Tillson, Field Application Scientist Manager ArcherDX, USA
Dr. Tan Swee Jin, Manager Scientific Affairs, Sysmex
Dr. Espen Walker, Medical Affairs Director, Roche
Dr. Subramanian Yegappan, Consultant Haematologist, PHKL
Prof. Dr. Noraidah Masir, Consultant Pathologist, HUKM
Dr. Hayani Abdul Wahid, Consultant Radiotherapist and Oncologist, Mahkota Medical Centre
Dr. Guan Yong Khe, Consultant Haematologist, Pantai Hospital Ayer Keroh
En Mohd Hareeff Bin Muhammed, CEO of Pantai Premier Pathology Sdn Bhd
Dr. Ros Suzanna Ahmad Bustaman, Head of Oncology & Radiotherapy Department, HKL
Dato’ Dr. Ibrahim Abd Wahid, Consultant Clinical Oncologist, Beacon Hospital
Dr. Ami Talib, Head of Pathologist Malaysia, HKL
Dato’ Dr. Vijaya Sangkar, Consultant Clinical Haematologist, Pantai Hospital KL
Dato’ Dr. Fuad Ismail, Consultant Oncologist Gleneagles Kuala Lumpur
Dr Mastura Md Yusof, Consultant Clinical Oncologist
Dato’ Dr. Sharifah Noor Akmal, Consultant Pathologist
Dr. Zubaidah Zakaria, Head of Cancer Research Centre (CaRC), IMR
Dr. Lam Kai Seng, Consultant Oncologist
Prof. Dr. Teo Soo-Hwang, CEO of Cancer Research Malaysia (CRM)